• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
8VI
Click for more information
0.00% 4.3¢

8VI HOLDINGS LIMITED

Market Cap $1.802M  ! watchlist Created with Sketch. Add to my watchlist
Consumer Defensive Education & Training Services

8VI Holdings Limited is a Singapore-based financial education technology company... 8VI Holdings Limited is a Singapore-based financial education technology company operating under the brand name VI. The Company operates through two segments: Financial Education and Others. Its Financial Education segment is engaged in providing financial education in the discipline of value investing and supporting a community of value investors globally under the VI brand. Its Others segment includes fintech businesses and subsidiaries that provide financial education and training in Taiwan and China. It offers GoodWhaled, a stock analysis tool developed through 8BIT Global Pte Ltd (8BIT), crunches traditional financial data and simplifies the complex stock analysis and decision-making process for equity investors into visuals under a framework. Its VI College is the financial education provider supporting a community of graduates and value investors globally through its investment and educational programs. Its subsidiaries include 8VI Malaysia Sdn. Bhd. and 8VI China Pte. Ltd.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
8VI
Ann: Cessation of Financial Advisory Operations 		09/02/24 0 239
09/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  239 
8VI
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		31/01/24 0 176
31/01/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  176 
8VI
Ann: Half Yearly Report & Accounts 		30/11/23 0 203
30/11/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  203 
8VI
Ann: Appendix 4D 		30/11/23 0 138
30/11/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  138 
8VI
Ann: Change of Directors' Interest Notice and Form 603 		09/11/23 0 216
09/11/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  216 
8VI
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		31/10/23 0 243
31/10/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  243 
8VI
Ann: Results of Annual General Meeting 		26/09/23 0 137
26/09/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  137 
8VI
Ann: 8VI AGM 2023 Presentation 		26/09/23 0 194
26/09/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  194 

See All Discussions arrow Created with Sketch.

Timeline

Cessation of Financial Advisory Operations
09 Feb 18:19
 
Quarterly Activities/Appendix 4C Cash Flow Report
31 Jan 18:59
 
Half Yearly Report & Accounts
30 Nov 18:01
 
Appendix 4D
30 Nov 17:58
 
Change of Directors' Interest Notice and Form 603
09 Nov 13:19
 
Quarterly Activities/Appendix 4C Cash Flow Report
31 Oct 17:00
 
View More arrow Created with Sketch.

Featured News

NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.
CC9 Chariot ends quarter charged up on lithium find in Wyoming
right-arrow Created with Sketch.
ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.
NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.

Latest Videos

8VI Holdings (ASX:8VI) appoints new CEO


03 Jan 2023 08:23 (AEDT)

(20min delay)
Last
4.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $1.802M
Open High Low Value Volume
4.3¢ 4.3¢ 4.3¢ $33 766

Buyers (Bids)

No. Vol. Price($)
3 58904 4.3¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 3000 1
View Market Depth
Last trade - 10.00am 26/04/2024 (20 minute delay) ?
8VI (ASX) Chart

Top Stories

Recce Pharmaceuticals up 6% on new antibiotic production milestone

Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Regal copper grades at Gascoyne play see shares jump 33% for Augustus Augustus Minerals is reporting high grade copper rock chip results at Ti-Tree in WA based on recent fieldwork.
Crypto world awaits overnight Bitcoin halving event The four-yearly Bitcoin halving is set to happen in the early hours of tomorrow morning (Saturday, April 20) - it's an event that industry leader Swyftx likened to 'the Olympic Games for the crypto industry'.
Recharged Prospects: 'Watts' on the horizon for copper & lithium The conversation goes much deeper that this title suggests - it explores everything from projections on aluminium & manganese, to what a Donald Trump government could mean for commodities markets.
Raiden’s jump into lithium territory in WA’s Pilbara echoes earlier journey by Azure In its bid to define a noteworthy lithium deposit in WA’s Pilbara region, Raiden Resources is following in the footsteps of another explorer.

Featured News

NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.
NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.
ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.
CC9 Chariot ends quarter charged up on lithium find in Wyoming
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.